Cell and Gene Therapy offer endless hopes to a wide range of illnesses. Adeno-Associated Viruses (AAV) are now at the forefront of new research.
Confectionery is usually associated with treats that are consumed to boost energy levels during the day. But, there’s a surprising new need emerging in the confectionery market: relaxation.
Consumers are paying more attention to the health effects of their food and beverages, including the sweeteners used in carbonated soft drinks (CSDs).
The new outbreak of Ebola in the Democratic Republic of Congo (DRC) has brought along with it a new chance to develop and prove ground-breaking vaccines and treatment.
Rising consumer demands for health and wellness products across the F&B marketplace have cascaded into the frozen foods segment. Trends such as vegan, keto, organic, and gluten-free have crossed the freezer door into frozen meals, and major brands are responding.
Keto and paleo dieters still look for ways to indulge without breaking their diet rules, so the chocolate and confectionery market has come out to meet them.
An exploration of the data reveals that the biggest challenge lies in CAR-T manufacturing, hence the high price tag.
As consumers become more familiar with the varying flavors of coffee beans, they demand a specialized experience that is customized to their tastes and preferences.
As consumers get more and more savvy, their need for increased effectiveness from the products they buy is growing.
As consumer behavior changes and product offerings rapidly diversify, the dairy-free ecosystem has become more dynamic. Both large and small players in dairy are taking action to leverage the opportunities presented in this high-growth, high-margin market.
Over the past several years more people adhere, at least partially, to a dietary preference. Natural, organic, vegan and gluten-free are among the most familiar ones.
The natural megatrend did not skip the oral care market. Signals Analytics identified the five most discussed oral care brands associated with natural ingredients.
Despite significant progress in the field, companies are still largely failing to address one of the most pertinent challenges associated with precision oncology.
A key unmet need facing psoriasis patients today is a lack of access to efficient medicines that are also attractive enough to ensure patient adherence to treatment regimens.
There has been a recent surge in research identifying CD47, known as the "don't eat me" molecule, as a target for cancer treatments.
Fitbit recently announced the release of a suite of apps and watch faces that integrate and connect the wearer with different healthcare companies, pharmacies and payers, specifically in the Diabetes, Oncology and wellness spaces.
As additional Big Pharma look to enter the field, the possibility of a healthcare bubble could be on the horizon, as small companies are bought out for too much, too early.